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SUMMARY. The objective of this study was to estimate the prevalence of adverse drug reactions (ADR)
related to hospital admission of elderly people, identifying the use of potentially inappropriate medication
(PIM) , the ADR and the risk factors associated with the hospitalization. A cross-sectional study was con-
ducted in a private hospital of São Paulo State, Brazil. All patients aged ≥ 60 years, admitted in the gener-
al practice ward in May 2006 were interviewed about the drugs used and the symptoms/complaints that
resulted in hospitalization. More than a half (54.5 %) of elderly hospitalizations were related with ADR.
The therapeutic classes involved with ADR were: cardiovascular (37.7 %), central nervous (34.6 %) and
respiratory (5.7 %). The ADR observed were disorders in circulatory (28.4 %), digestive (20.0 %) and res-
piratory (18.9 %) tracts. 27 elderly had made PIM and in 20 of them this was the cause of hospitalization.
Polypharmacy was an ADR risk factor (p = 0.021).These data allows the healthcare professionals upgrade,
qualifying them in pharmcovigilance. 
